137 related articles for article (PubMed ID: 22608917)
1. L-Carnitine: an adequate supplement for a multi-targeted anti-wasting therapy in cancer.
Busquets S; Serpe R; Toledo M; Betancourt A; Marmonti E; Orpí M; Pin F; Capdevila E; Madeddu C; López-Soriano FJ; Mantovani G; Macciò A; Argilés JM
Clin Nutr; 2012 Dec; 31(6):889-95. PubMed ID: 22608917
[TBL] [Abstract][Full Text] [Related]
2. Differential structural features in soleus and gastrocnemius of carnitine-treated cancer cachectic rats.
Busquets S; Pérez-Peiró M; Salazar-Degracia A; Argilés JM; Serpe R; Rojano-Toimil A; López-Soriano FJ; Barreiro E
J Cell Physiol; 2020 Jan; 235(1):526-537. PubMed ID: 31241186
[TBL] [Abstract][Full Text] [Related]
3. Nutraceutical inhibition of muscle proteolysis: a role of diallyl sulphide in the treatment of muscle wasting.
Olivan M; Busquets S; Figueras M; Fontes de Oliveira C; Toledo M; Sette A; Ventura da Silva P; Barberis P; Argilés JM; López-Soriano FJ
Clin Nutr; 2011 Feb; 30(1):33-7. PubMed ID: 20655130
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats.
Figueras M; Busquets S; Carbó N; Barreiro E; Almendro V; Argilés JM; López-Soriano FJ
FEBS Lett; 2004 Jul; 569(1-3):201-6. PubMed ID: 15225634
[TBL] [Abstract][Full Text] [Related]
5. Formoterol fumarate and roxithromycin effects on muscle mass in an animal model of cancer cachexia.
Kenley RA; Denissenko MF; Mullin RJ; Story J; Ekblom J
Oncol Rep; 2008 May; 19(5):1113-21. PubMed ID: 18425366
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats.
Carbó N; López-Soriano J; Costelli P; Busquets S; Alvarez B; Baccino FM; Quinn LS; López-Soriano FJ; Argilés JM
Br J Cancer; 2000 Aug; 83(4):526-31. PubMed ID: 10945502
[TBL] [Abstract][Full Text] [Related]
7. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.
Busquets S; Figueras MT; Fuster G; Almendro V; Moore-Carrasco R; Ametller E; Argilés JM; López-Soriano FJ
Cancer Res; 2004 Sep; 64(18):6725-31. PubMed ID: 15374990
[TBL] [Abstract][Full Text] [Related]
8. β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia.
Aversa Z; Bonetto A; Costelli P; Minero VG; Penna F; Baccino FM; Lucia S; Rossi Fanelli F; Muscaritoli M
Int J Oncol; 2011 Mar; 38(3):713-20. PubMed ID: 21184031
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models.
Busquets S; Fuster G; Ametller E; Olivan M; Figueras M; Costelli P; Carbó N; Argilés JM; López-Soriano FJ
Clin Nutr; 2007 Apr; 26(2):239-44. PubMed ID: 17261345
[TBL] [Abstract][Full Text] [Related]
10. L-Carnitine induces recovery of liver lipid metabolism in cancer cachexia.
Silvério R; Laviano A; Rossi Fanelli F; Seelaender M
Amino Acids; 2012 May; 42(5):1783-92. PubMed ID: 21465256
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of skeletal muscle atrophy in cancer cachexia by D-myo-inositol 1,2,6-triphosphate.
Russell ST; Siren PM; Siren MJ; Tisdale MJ
Cancer Chemother Pharmacol; 2009 Aug; 64(3):517-27. PubMed ID: 19112551
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice.
Siddiqui RA; Hassan S; Harvey KA; Rasool T; Das T; Mukerji P; DeMichele S
Br J Nutr; 2009 Oct; 102(7):967-75. PubMed ID: 19393114
[TBL] [Abstract][Full Text] [Related]
13. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin-proteasome and the mitochondria-associated apoptotic pathways are sequentially downregulated during recovery after immobilization-induced muscle atrophy.
Vazeille E; Codran A; Claustre A; Averous J; Listrat A; Béchet D; Taillandier D; Dardevet D; Attaix D; Combaret L
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1181-90. PubMed ID: 18812460
[TBL] [Abstract][Full Text] [Related]
15. Effects of the beta
Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
[TBL] [Abstract][Full Text] [Related]
16. The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia.
Moore-Carrasco R; Busquets S; Almendro V; Palanki M; López-Soriano FJ; Argilés JM
Int J Oncol; 2007 May; 30(5):1239-45. PubMed ID: 17390027
[TBL] [Abstract][Full Text] [Related]
17. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
Elkina Y; Palus S; Tschirner A; Hartmann K; von Haehling S; Doehner W; Mayer U; Coats AJ; Beadle J; Anker SD; Springer J
Int J Cardiol; 2013 Dec; 170(2):160-6. PubMed ID: 24207070
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
Trobec K; Palus S; Tschirner A; von Haehling S; Doehner W; Lainscak M; Anker SD; Springer J
Nutrition; 2014 Sep; 30(9):1069-75. PubMed ID: 24976415
[TBL] [Abstract][Full Text] [Related]
19. Curcumin treatment prevents increased proteasome and apoptosome activities in rat skeletal muscle during reloading and improves subsequent recovery.
Vazeille E; Slimani L; Claustre A; Magne H; Labas R; Béchet D; Taillandier D; Dardevet D; Astruc T; Attaix D; Combaret L
J Nutr Biochem; 2012 Mar; 23(3):245-51. PubMed ID: 21497497
[TBL] [Abstract][Full Text] [Related]
20. Supplementation with l-carnitine downregulates genes of the ubiquitin proteasome system in the skeletal muscle and liver of piglets.
Keller J; Ringseis R; Koc A; Lukas I; Kluge H; Eder K
Animal; 2012 Jan; 6(1):70-8. PubMed ID: 22436156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
